Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Biogen Idec is recruiting participants for its 'EMPOWER' trial, which will study the effects of the experimental treatment dexpramipexole in ALS
Posted on Thursday, March 31, 2011 - 05:30, By: Amy Madsen
Update 8/31/11: Enrollment screening for this study has closed to new prospective participants.
Posted on Saturday, May 1, 2010 - 11:54, By: ALSN Staff
Cytokinetics seeks participants for CK-2017357 study
Cytokinetics, a South San Francisco biotechnology company, is seeking participants with ALS for a trial of its experimental compound CK-2017357.